SciencePediaThe field of immune metabolism explores how immune cells manage energy and material resources to perform their duties, revealing that a cell's metabolic state is inextricably linked to its function. For decades, immunology and metabolism were studied as separate disciplines, but we now understand their profound connection is central to health and disease. This article addresses the knowledge gap by explaining how the logistics of cellular fuel—the choice between burning fast for an attack or slow for surveillance—is the deciding factor in an immune response. You will learn the core principles governing these metabolic decisions and see how this new understanding provides a unifying framework for viewing infection, cancer, autoimmunity, and aging. The following chapters will first delve into the fundamental Principles and Mechanisms inside the cell, before exploring the wide-ranging Applications and Interdisciplinary Connections that place immunometabolism at the forefront of modern biology and medicine.
Imagine peering inside an immune cell, not as a static diagram in a textbook, but as a bustling city. This city has factories, power plants, communication networks, and a standing army. The study of immune metabolism is like being the city planner and quartermaster rolled into one. It’s about understanding how this city manages its resources—food, energy, and raw materials—to decide whether to live in a state of peaceful vigilance, to mount a furious defense against an invader, or to calm things down after a battle. It’s the science of the immune system’s logistics, and in logistics, as in war, lie the keys to victory and defeat.
Every cell, including our immune defenders, has a standard set of biochemical machinery for processing fuel. Think of these as different kinds of engines in the cell’s garage, each with its own purpose, speed, and efficiency. The main fuel is often glucose, a simple sugar.
The first engine is glycolysis. It’s a rapid, ten-step assembly line in the cell’s main workspace, the cytosol. It takes one molecule of glucose and quickly splits it into two smaller molecules of pyruvate. In the process, it generates a tiny but immediate puff of energy in the form of adenosine triphosphate (ATP), the universal energy currency of the cell, along with some high-energy electrons stored in a molecule called NADH.
Now, the cell has a choice. If it needs a massive amount of energy and has time, it sends the pyruvate to the specialized power plants: the mitochondria. Inside the mitochondrial matrix, pyruvate is converted to a molecule called acetyl-CoA, which enters the tricarboxylic acid (TCA) cycle (also known as the Krebs cycle). This cycle is a sophisticated roundabout that methodically tears apart the acetyl-CoA, harvesting a huge bounty of high-energy electrons and storing them in NADH and another carrier, FADH₂.
These electron carriers then deliver their precious cargo to the final, and most powerful, engine: oxidative phosphorylation (OxPhos). This process, occurring on the inner mitochondrial membrane, is an engineering marvel. The electrons are passed down a chain of protein complexes, releasing energy at each step to pump protons across the membrane. This creates an electrical and chemical gradient—a dam holding back a reservoir of potential energy. The protons then rush back through a molecular turbine called ATP synthase, which spins like a water wheel to churn out massive quantities of ATP. This is the slow, steady, and incredibly efficient way to make energy.
But that’s not the whole story. Cells also have workshops for building things. The pentose phosphate pathway (PPP) is an off-ramp from glycolysis that, instead of making energy, produces two critical building materials: ribose-5-phosphate, a necessary component of DNA and RNA, and a special electron carrier called NADPH, the primary currency for building molecules and defusing dangerous oxidants. Likewise, pathways like fatty acid synthesis (FAS) and fatty acid oxidation (FAO) allow the cell to build or burn fats, respectively, for membranes or for fuel.
Here lies the central drama of immune metabolism. A resting, patrolling immune cell, like a city in peacetime, values efficiency. It primarily uses the full, three-stage process: glycolysis, the TCA cycle, and finally oxidative phosphorylation to slowly burn fuels like glucose or fatty acids, squeezing out every last drop of ATP. This is the "slow and steady" approach, perfect for long-term survival and surveillance.
But when the alarm sounds—when a pathogen is detected—everything changes. An activated macrophage or a T cell preparing for battle doesn't have time for efficiency. It needs to act now. It needs to build weapons, produce chemical signals, and, in the case of T cells, divide into a vast army of clones. For this, it makes a surprising choice. It dramatically ramps up glycolysis but then, for the most part, stops sending the pyruvate to the mitochondria for OxPhos. Instead, it converts the pyruvate into lactate and excretes it. This is aerobic glycolysis, so named because it happens even when plenty of oxygen is available for the "better" pathway.
Why on earth would a cell adopt such a seemingly wasteful strategy? It’s like flooring the gas pedal on a car and getting terrible mileage. The answer is that ATP is not the only thing the cell needs. This "fast and furious" metabolism, while poor at making ATP per molecule of glucose, is incredibly fast and serves two other vital purposes:
Speed: It generates ATP much more quickly than the full OxPhos pathway, providing immediate energy for acute functions. This rapid, "inefficient" burning of glucose also releases more energy as heat. This microscopic metabolic shift is a direct contributor to one of the cardinal signs of inflammation you can feel: calor, the heat of an infected wound.
Building Blocks: By running glycolysis at high speed and shunting intermediates away, the cell can divert the flow of carbon into side-pathways like the pentose phosphate pathway and fatty acid synthesis. This provides the raw materials—the NADPH, the nucleotide precursors, the lipids—needed to build an arsenal of antimicrobial molecules and, for a T cell, to construct billions of daughter cells.
The beauty of the immune system is how different cells tune their metabolism to their specific job description. The choice between "fast and furious" glycolysis and "slow and steady" OxPhos is not random; it is perfectly matched to the cell's function.
Consider a pro-inflammatory macrophage (M1), the cellular equivalent of a front-line soldier. Its job is to engulf and destroy invaders. One of its most potent weapons is the respiratory burst, a process where it generates a cloud of highly toxic reactive oxygen species (ROS) to kill pathogens. This weapon is powered by the enzyme NADPH oxidase, and as its name suggests, it consumes vast amounts of NADPH. Where does this NADPH come from? From the pentose phosphate pathway, which runs off the high-flux glycolytic program. If you block glycolysis in these macrophages, you starve the PPP of its substrate. The NADPH supply dries up, the respiratory burst fails, and the macrophage can no longer kill bacteria effectively.
Now consider a completely different cell: a regulatory T cell (Treg). Its job is not to fight but to suppress immune responses, acting as a peacekeeper to prevent autoimmunity and limit collateral damage. This is a long-term, sustained job that requires endurance, not a short burst of activity. Accordingly, Tregs don't rely on the frenetic pace of aerobic glycolysis. Instead, they power their suppressive functions by steadily burning fatty acids through fatty acid oxidation (FAO) to fuel the highly efficient engine of oxidative phosphorylation. If you block their ability to burn fats—for instance, by inhibiting the CPT1 enzyme that imports fatty acids into the mitochondria—their ability to keep the peace falters.
This dichotomy is a unifying principle: glycolysis fuels the fighters, while oxidative phosphorylation sustains the peacekeepers and the sentinels.
How does a cell make this profound metabolic decision? It doesn't happen by magic. The cell has a sophisticated command-and-control system built around two master protein kinases that act like generals in the resource management office: mTOR and AMPK.
mTOR (mechanistic Target of Rapamycin) is the "go-anabolic" or "attack" general. It is activated by signals of abundance: plenty of nutrients (like amino acids) and growth factor signals, which are often present alongside the "danger" signals that activate an immune cell. When mTOR is active, it promotes a cascade of events that re-wire the cell for growth and pro-inflammatory function. For instance, in a neutrophil that has detected an invader, signaling pathways activate mTOR, which in turn unleashes transcription factors like HIF-1α. HIF-1α then commands the cell to produce more glycolytic enzymes, forcing the switch to the "fast and furious" metabolic state needed to fuel potent effector functions like ROS production and the release of Neutrophil Extracellular Traps (NETs).
AMPK (AMP-activated protein kinase) is the opposing general, the master of conservation and catabolism. It is activated by signals of scarcity, specifically a low cellular energy charge (a high ratio of AMP to ATP). When a cell is low on energy, AMPK swings into action. It puts the brakes on energy-intensive anabolic processes, like those driven by mTOR, and cranks up catabolic, energy-generating pathways like fatty acid oxidation and mitochondrial biogenesis. In the immune system, AMPK activity favors the "slow and steady" metabolic states associated with longevity, restraint, and memory—such as in regulatory T cells or long-lived memory T cells.
This elegant push-and-pull between mTOR and AMPK allows an immune cell to integrate information about its environment (Are there nutrients? Is there danger?) and its internal state (Is my energy low?) to make a rational metabolic decision that is perfectly tailored to the immunological task at hand.
For a long time, we thought of mitochondria simply as the cell's "powerhouses." But we now understand they are also critical signaling hubs and sentinels of cellular health. When mitochondria are damaged or stressed, they don't just fail to produce energy; they actively sound the alarm, broadcasting "danger" signals to the rest of the cell.
One of the most dramatic ways they do this is by leaking their own DNA. Mitochondrial DNA (mtDNA) is structurally similar to bacterial DNA. If it escapes from the mitochondrion and appears in the cytosol—a place it should never be—the cell's innate immune system immediately recognizes it as a sign of trouble. A cytosolic DNA sensor called cGAS binds to the rogue mtDNA and triggers the STING signaling pathway, leading to the production of potent antiviral and pro-inflammatory signals like type I interferons. This is the cell's internal "danger model" in action: the mislocalization of a self-molecule signals a breach in homeostasis.
But it goes even deeper. A metabolic state itself can become an inflammatory signal. The high-flux glycolytic program of an activated macrophage can cause a "traffic jam" in the TCA cycle. An intermediate called succinate can build up and leak out of the cycle. This succinate can promote the production of mitochondrial ROS, which are not just damaging byproducts but also potent signaling molecules. This mROS can directly trigger the assembly of the NLRP3 inflammasome, a protein complex that acts as a megaphone for inflammation by activating the powerful cytokine Interleukin-1β. In this way, the choice of a metabolic program doesn't just fuel the inflammatory response; it actively amplifies it by generating its own internal danger signals.
Perhaps the most fascinating discovery in recent years is that these metabolic shifts can leave a lasting legacy. A prior encounter with a pathogen can "train" an innate immune cell, like a monocyte or macrophage, to respond more robustly to a future challenge, even one from a completely unrelated microbe. This phenomenon, called trained immunity, is distinct from the highly specific memory of the adaptive immune system and is fundamentally driven by metabolism and epigenetics.
Here’s how it works: the initial inflammatory signal triggers the switch to aerobic glycolysis. A byproduct of this metabolic state is an abundance of acetyl-CoA in the cytosol and nucleus. This acetyl-CoA is the essential building block for adding acetyl groups to histones—the proteins around which DNA is wound. This modification, called histone acetylation, pries the DNA open, making genes more accessible for transcription. At inflammatory gene loci, these metabolic changes leave behind epigenetic marks that don't go away. The "trained" cell is now poised, with its inflammatory genes primed and ready, to launch a faster and stronger attack the next time it sees a threat. Metabolism has effectively written memory into the cell's hardware.
But this powerful adaptation can have a dark side. The resource-allocation trade-offs that are beneficial for fighting acute infection may become detrimental in the long run. A "trained" monocyte, perpetually in a state of heightened metabolic and inflammatory readiness, may be more likely to overreact to chronic, low-grade stimuli. For instance, these hyper-responsive cells may encounter oxidized LDL cholesterol in the wall of an artery. Mistaking this for a danger signal, they can unleash a furious inflammatory response via the NLRP3 inflammasome, contributing to the formation of atherosclerotic plaques. The very mechanism that provides enhanced protection against infection might, in a different context, increase the risk of heart disease.
From the basic chemistry of a sugar molecule to the cellular logistics of war, from the command-and-control decisions of sensor proteins to the long-term epigenetic scars that shape chronic disease, immune metabolism reveals a stunning unity of principle. It shows us that to understand immunity, we must understand the beautiful and intricate logic of how a cell manages its energy and its resources.
In our journey so far, we have taken a close look at the intricate machinery within our immune cells. We’ve admired the elegant dance of molecules in metabolic pathways, the chemical logic that converts a simple sugar into the energy of life or the building blocks of a cellular warrior. We’ve seen how an immune cell decides whether to burn its fuel slowly and efficiently, like a marathon runner, or to ignite it in a rapid, explosive burst, like a sprinter.
Now, we zoom out. We leave the engine room and ascend to the command deck to see how the hum of these cellular engines orchestrates the grand drama of health and disease. You see, the principles of immunometabolism are not just abstract biochemical rules; they are the very language of life and death in a complex organism. They are at play in a feverish battle against a virus, in the slow, creeping siege of cancer, in the remarkable preventative power of a vaccine, and even in the subtle changes that accompany the passage of years. Let us now explore this vast landscape, and you will see how this single, unifying concept—that an immune cell’s function is dictated by its fuel—offers a new and profound understanding of biology.
Every infection is a form of metabolic warfare. When a pathogen invades, it isn't just seeking a place to hide; it is looking for resources—a source of energy and materials to build copies of itself. To do this, it must hijack the host cell's metabolic machinery. Pathogens, through eons of evolution, have become master metabolic engineers.
Consider the different strategies employed by a virus versus an intracellular bacterium. Many viruses, upon infecting a cell, act like bandits in a hurry. They need to replicate fast. To do this, they often trigger signaling pathways like PI3K-AKT-mTORC1, which effectively floors the accelerator on the host cell’s glucose consumption. The cell is forced into a state of rapid, inefficient glycolysis—the "Warburg effect"—burning through sugar to quickly generate energy and, more importantly, the carbon scaffolds needed for viral parts. The host cell, now a hijacked factory, churns out new viruses at a frantic pace.
In contrast, some intracellular bacteria prefer a stealthier approach. They don’t want a quick smash-and-grab; they want to set up a long-term residence inside an immune cell, like a macrophage. To do this, they secrete proteins, called effectors, that rewire the macrophage’s metabolism to their liking. Instead of promoting glycolysis, these effectors might push the cell toward burning fats through fatty acid oxidation (FAO). This creates a more stable, less inflammatory environment, allowing the bacteria to persist quietly without triggering a full-blown alarm. It is a metabolic tug-of-war, with the pathogen and the host cell each trying to seize control of the metabolic switches.
The host, of course, is not a passive victim. It has its own metabolic weapons. One of the most ancient and elegant of these is called "nutritional immunity". Think of a vital resource like iron. For nearly all living things, including bacteria, iron is an indispensable cofactor for enzymes involved in the most fundamental processes of life: cellular respiration and DNA replication. Without iron, an organism cannot produce energy or multiply. Our bodies know this. During an infection, the host immune system launches a systemic campaign to hide its iron. Proteins that bind iron are released in droves, and a key hormone called hepcidin signals our cells to pull their iron exporters off the surface. Free iron vanishes from the bloodstream, effectively starving the invading bacteria of a nutrient they cannot live without. It is a simple, brilliant strategy of resource denial, a scorched-earth policy written in the language of biochemistry.
In chronic infections, like tuberculosis, we can even visualize this metabolic struggle in patients. An organized structure called a granuloma forms in the lungs—a spherical fortress of immune cells trying to contain the bacteria. Using a medical imaging technique called Positron Emission Tomography (PET), we can see the granuloma's metabolic architecture. By injecting a radioactive sugar analog (-FDG), we see a glowing, hyper-metabolic ring of activated macrophages and T cells on the granuloma's outer edge, all furiously consuming glucose to maintain the siege. Yet, by using a different tracer (-FMISO) that accumulates in low-oxygen areas, we can see a "hypoxic zone" deeper inside, where the intense cellular activity has depleted the oxygen supply. The granuloma is not a uniform blob; it is a miniature city with distinct metabolic neighborhoods, each with a different role in the chronic battle.
The same principles that govern wars against foreign invaders also apply to civil wars—when the body turns against itself. Cancer is one such war. A tumor is not just a collection of malignant cells; it is a corrupt ecosystem that manipulates its environment to survive and grow. At the heart of this manipulation lies metabolism.
Solid tumors are often poorly supplied with blood vessels, creating pockets of severe oxygen deprivation, or hypoxia. This triggers a survival program run by a master transcription factor called Hypoxia-Inducible Factor-1α (HIF-1α). HIF-1α forces the cancer cells into a glycolytic state, producing massive amounts of lactate as a byproduct. This lactate, once thought to be a mere waste product, is now understood to be a key weapon. It acidifies the local environment, creating a toxic moat that cripples or kills incoming anti-tumor T cells. Furthermore, this hypoxic, HIF-1α-driven state directly causes the cancer cells (and co-opted immune cells) to display the protein PD-L1 on their surface. This protein is a "don't kill me" signal that engages with the PD-1 receptor on T cells, shutting them down. Here we see a direct, causal chain: low oxygen leads to a metabolic shift, which in turn leads to immune suppression. This insight is the foundation for modern cancer immunotherapies that block the PD-1/PD-L1 interaction, effectively disarming the tumor's metabolic shield.
The immune system can also err in the other direction, launching an unprovoked attack on the body's own tissues, leading to autoimmune disease. Here, too, metabolism is a key arbiter. The decision for a T cell to become a pro-inflammatory warrior (Th17) or a peace-keeping regulator (Treg) is profoundly influenced by its metabolic environment. This environment, fascinatingly, is shaped by the trillions of microbes living in our gut. Our gut bacteria digest the food we cannot and, in the process, produce a symphony of small molecules called metabolites. These metabolites are absorbed and can act as fuel and signals for our immune cells. For instance, a diet rich in fiber promotes bacteria that produce butyrate, a short-chain fatty acid that encourages T cells to become anti-inflammatory Tregs. In contrast, a different microbial community might produce succinate, which can push T cells toward the pro-inflammatory Th17 fate. A dysbiotic shift in our gut microbiome can therefore alter the "metabolic diet" of our local immune cells, tipping the balance from tolerance to autoimmunity. This reveals a sublime connection between our diet, our microbes, and the state of our immune system.
If metabolism is at the center of the problem, it must also be at the center of the solution. The most advanced frontiers in medicine are now actively harnessing immunometabolism to design more effective vaccines and therapies.
Consider the remarkable success of mRNA vaccines. Why are they so effective at generating potent cytotoxic T-lymphocytes (CTLs), the "killer" T cells needed to eliminate virally infected cells? A major part of the answer lies in how they metabolically program dendritic cells (DCs), the conductors of the immune response. When an mRNA vaccine delivers its payload into a DC, the cell is forced into a sudden, massive protein synthesis effort. This overloads the cell's protein-folding machinery, causing "ER stress." The cell responds by activating a process called autophagy and temporarily throttling the central metabolic regulator, mTORC1. This specific sequence of metabolic events turns out to be ideal for promoting the processing and presentation of the viral antigen on MHC class I molecules—the precise signal needed to activate a powerful CTL response. In contrast, a traditional alum-adjuvanted subunit vaccine induces a different, more sustained metabolic program in the DC that is better suited for activating antibody-producing helper T cells. The vaccine is not just delivering an antigen; it is delivering a metabolic instruction manual.
Some vaccines even have benefits that go far beyond their intended target. The tuberculosis vaccine, BCG, is known to provide children with broad protection against a range of other respiratory infections. This phenomenon is explained by "trained immunity". BCG doesn't just create T cell memory for tuberculosis; it leaves a long-lasting metabolic and epigenetic imprint on our innate immune cells, like monocytes and macrophages. This "training" rewires their baseline metabolism, priming them to respond faster and more robustly to any future challenge. They become more glycolytic, their genes for inflammatory responses more accessible. In essence, the vaccine provides a general fitness program for the innate immune system, with metabolic reprogramming as its core curriculum.
This focus on metabolic fitness is now in revolutionizing cell-based therapies for cancer, such as CAR T-cell therapy. In this procedure, a patient's own T cells are engineered to recognize and kill their cancer. But which T cells should we choose for this engineering? It turns out that the starting population's metabolic health is a critical predictor of success. A product made from "younger," less-differentiated T cells (like naive or central memory T cells) works best. These cells have a higher proliferative potential and, crucially, superior mitochondrial fitness. They have a high "spare respiratory capacity," meaning their mitochondria have reserve power they can tap into when faced with the marathon stress of fighting a tumor. In contrast, starting with terminally differentiated, exhausted T cells, which are often highly glycolytic and have poor mitochondrial reserves, results in a therapy that poops out quickly. We are no longer just manufacturing a drug; we are selecting and conditioning metabolic athletes for a fight to the death.
The principles of immunometabolism are not confined to the immune system. They are part of a body-wide symphony of metabolic communication that connects all of our organs.
In the brain, after an injury like a stroke, a beautiful example of metabolic cooperation unfolds. Astrocytes, the support cells of the nervous system, switch to a highly glycolytic state, much like an activated macrophage. They take up glucose and produce lactate, which they then export. This lactate serves as a vital fuel source for two different populations: the injured, energy-starved neurons trying to survive, and the responding immune cells (microglia and macrophages) that are cleaning up the damage. This "astrocyte-neuron lactate shuttle" shows how tissues can orchestrate a shared metabolic response to crisis.
The endocrine system, which controls our body's hormones, is also deeply intertwined with immunometabolism. Thyroid hormone, the body's master thermostat, is essential for supporting the high metabolic demands of an activated immune system. It boosts mitochondrial function and glucose utilization in immune cells. During a severe illness, however, the body makes a strategic decision. To conserve energy for the most vital functions, it activates a state called "non-thyroidal illness syndrome," where the production of active thyroid hormone is temporarily suppressed. This is a system-wide executive order to dial down the global metabolic rate, a trade-off that highlights the delicate balance between fueling a robust defense and preventing systemic collapse.
Finally, immunometabolism provides a powerful lens through which to understand aging and the impact of lifestyle. One of the hallmarks of aging is a chronic, low-grade systemic inflammation dubbed "inflammaging." Adipose tissue, or body fat, is a major source of this inflammation. Macrophages residing in fat tissue can adopt a pro-inflammatory, glycolytic state, especially in the context of obesity and aging. One of the most robust ways to combat this is caloric restriction. By limiting nutrient availability, caloric restriction appears to force these adipose tissue macrophages to shift their metabolism away from wasteful glycolysis and toward more efficient oxidative phosphorylation. This metabolic switch is coupled to a functional switch toward an anti-inflammatory state, reducing the secretion of inflammatory cytokines and thus lowering the systemic "inflammaging" burden. Here we find a direct, molecular explanation for how what we eat can shape the inflammatory tone of our bodies over a lifetime.
From the molecular subterfuge of a virus to the promise of a living cancer therapy, from the invisible world of gut microbes to the tangible process of aging, immunometabolism provides a unifying thread. It reveals a hidden layer of regulation, a dynamic conversation about energy that underpins the function of every immune cell, and by extension, the health of the entire organism. It is a beautiful testament to the idea that in biology, to understand how a thing works, one must first ask: what powers it?